<?xml version="1.0" encoding="UTF-8"?>
<NDC>
<NDCCode>
51662-1652-1
</NDCCode>
<PackageDescription>
1 SYRINGE in 1 SYRINGE (51662-1652-1) / 6 mL in 1 SYRINGE
</PackageDescription>
<NDC11Code>
51662-1652-01
</NDC11Code>
<ProductNDC>
51662-1652
</ProductNDC>
<ProductTypeName>
HUMAN PRESCRIPTION DRUG
</ProductTypeName>
<ProprietaryName>
Glydo- Lidocaine Hydrochloride Jelly
</ProprietaryName>
<ProprietaryNameSuffix/>
<NonProprietaryName>
Glydo- Lidocaine Hydrochloride Jelly
</NonProprietaryName>
<DosageFormName>
JELLY
</DosageFormName>
<RouteName>
TOPICAL
</RouteName>
<StartMarketingDate>
20140915
</StartMarketingDate>
<EndMarketingDate/>
<MarketingCategoryName>
ANDA
</MarketingCategoryName>
<ApplicationNumber>
ANDA201094
</ApplicationNumber>
<LabelerName>
HF Acquisition Co. LLC, DBA HealthFirst
</LabelerName>
<SubstanceName>
LIDOCAINE HYDROCHLORIDE ANHYDROUS
</SubstanceName>
<StrengthNumber>
20
</StrengthNumber>
<StrengthUnit>
mg/mL
</StrengthUnit>
<Pharm_Classes>
Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]
</Pharm_Classes>
<DEASchedule/>
<Status>
Active
</Status>
<LastUpdate>
2025-04-24
</LastUpdate>
<PackageNdcExcludeFlag>
N
</PackageNdcExcludeFlag>
<ProductNdcExcludeFlag>
N
</ProductNdcExcludeFlag>
<ListingRecordCertifiedThrough>
20261231
</ListingRecordCertifiedThrough>
<StartMarketingDatePackage>
20140915
</StartMarketingDatePackage>
<EndMarketingDatePackage/>
<SamplePackage>
N
</SamplePackage>
</NDC>